Elanco Animal Health (ELAN) Tops Q2 EPS by 11c

Elanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.36, $0.11 better than the analyst estimate of $0.25. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.18 billion.

GUIDANCE:

Elanco Animal Health sees Q3 2022 EPS of $0.12-$0.18, versus the consensus of $0.26. Elanco Animal Health sees Q3 2022 revenue of $1.01-1.06 billion, versus the consensus of $1.14 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• SAP Q1 results fall short of Wall Street estimates as transformation kicks off
• Globe Life Inc. (GL) Misses Q1 EPS by 1c, Offers Guidance
• Cathay General Bancorp (CATY) Reports In-Line Q1 EPS